Daniel R. Saban, PhD is the recipient of the 2024 Cogan Award, presented by the Association for Research in Vision and Ophthalmology (ARVO). This prestigious award recognizes young researchers that have made significant contributions to research in ophthalmology or visual science, and that show substantial promise for future contributions in this field.   

Duke University researchers created a computer program that determines, with 94% accuracy, if a person's age-related macular degeneration (AMD) will worsen within a year.  

Goldis Malek, PhD, Vice Chair of Equity, Diversity and Inclusion and Associate Professor in Ophthalmology, Pathology, and Cell Biology is the 2022 recipient of the RSF Awards in Science for Journal of Ocular Pharmacology and Therapeutics. This award is presented by Mary Ann Liebert, Inc. and the Rosalind Franklin Society to recognize outstanding published peer-reviewed research by women and underrepresented minorities in science. 

DURHAM, N.C. – A machine learning model developed by Duke Health researchers can differentiate normal cognition from mild cognitive impairment using retinal images from the eye.

Duke Eye Center is proud to announce that Eleonora Lad, MD, PhD has been named Vice Chair for Clinical Research. Lad is a clinician scientist and retinal ophthalmologist with an extensive background in research, both as an investigator and in her role as Director of Clinical Research Unit (CRU).

Sarah Eom, PhD student in the Pratt School of Engineering, will present her research on "Edge-based Augmented Reality (AR) Guidance System for Retinal Laser Therapy via Feature Matching" at the 22nd International Conference on Information Processing in Sensor Networks held May 9-12, 2023 in San Antonio, TX. 

The annual meeting for the Association of Research in Vision and Ophthalmology (ARVO) will be held April 23-27 in New Orleans, LA. There will be 100 presentations by Duke faculty and trainees. Paloma Liton, PhD and Anthony Kuo, MD served on the 2023 ARVO Meeting Planning Committee. 

View a Full List of Duke Presentations

On February 17, 2023, the U.S. Food and Drug Administration (FDA) approved a groundbreaking treatment to treat geographic atrophy (GA), an advanced form of dry macular degeneration (AMD). Eleonora Lad, MD, PhD, director of clinical research and associate professor, was a lead investigator in the OAKS trial, a pivotal clinical trial that supported the FDA approval.

Duke School of Medicine has received more than $527 million in federal funding from the National Institute of Health (NIH) in 2022, ranking ninth nationally, according to the Blue Ridge Institute for Medical Research. Duke Ophthalmology is one of eight clinical science departments and two basic science departments in the School of Medicine to rank among the top 10 in the country - receiving over $10 million in NIH funding in 2022.

Duke Eye Center is participating in two pivotal gene therapy clinical trials, ATMOSPHERE and ASCENT that may become promising treatments for age-related macular degeneration.  The studies, are large multisite trials, and Duke is the lead site for ASCENT and Lejla Vajzovic, MD is the lead PI for the trial.